Clinical Trial Update: Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab plus chemotherapy followed by definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED